Yahoo Web Search

Search results

  1. Jul 29, 2015 · Biography. Dr. Zheng received his PhD in 1999 from SUNY Buffalo in Medicinal Chemistry. Following two years of postdoctoral training in photodynamic therapy at the Roswell Park Cancer Institute, he joined the University of Pennsylvania in 2001 as an Assistant Professor of Radiology, where he established the molecular imaging chemistry program ...

    • Focus Areas
    • Significance to Patient Care
    • Professional Highlights
    Dr. Zheng is focused on implementing cutting-edge molecular technologies in clinical diagnostics — including circulating cell-free DNA (cfDNA) cancer tests based on next-generation sequencing — and...
    He is using data mining to improve genomics data interpretation and identify clinically relevant disease entities based on genomic markers.

    The study of disease on the molecular level (molecular pathology) is intimately related to precision medicine. Molecular pathology provides important diagnostic, prognostic and therapeutic information to guide treatment for patients with cancer.

    Member, editorial board, Journal of Applied Laboratory Medicine, 2019-present
    Expert adviser for molecular diagnostics, Clinical and Laboratory Standards Institute, 2020
    Review editor, Hematologic Malignancies, Frontiers in Oncology, 2020
    Vice chair, Molecular Analysis committee, International Society for Laboratory Hematology, 2020
  2. People also ask

  3. Dr. Gang Zheng is board certified in both molecular pathology and hematopathology. He is a co-director of Mayo Clinical genomics laboratory and a professor of the department of laboratory medicine and pathology. Dr.

  4. Zheng G, He R, Reichard KK, Peterson JF, Olteanu H, Oliveira JL, Rangan A, Chen D, Shi M. Genetic and Clinical Studies of Patients With Increased Multinucleated Megakaryocytes in Bone Marrow as an Isolated Finding: A Diagnostic Pitfall for Myelodysplastic Syndrome. Am J Surg Pathol. 2021 Nov 1; 45 (11):1534-1540.

  5. ACS nano 7 (3), 2541-2550. , 2013. 387. 2013. Photodynamic molecular beacon as an activatable photosensitizer based on protease-controlled singlet oxygen quenching and activation. G Zheng, J Chen, K Stefflova, M Jarvi, H Li, BC Wilson. Proceedings of the National Academy of Sciences 104 (21), 8989-8994.

  1. People also search for